10-Jun-2008 - Royal Society of Chemistry (RSC)

Tagging-detagging for purification of radiotracers

Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a novel tagging-detagging strategy. This could be extremely useful for the purification of known and novel 18F-radiotracers for Positron Emission Tomography. It is the first detagging process to rely on a C-F bond forming event and they have shown its feasibility. To do this they synthesised fluorous allylsilanes by cross metathesis and then fluorinated them via an electrophilic substitution, using Selectfluor as the detagging reagent. Using this new method, both the fluorination and the detagging occur in the last step of the sequence. The F-target can therefore be separated from the precursor using FSPE (fluorous solid phase extraction), dramatically reducing the time required to produce the pure final product.

Their next goal will be to demonstrate that this chemistry can be done "hot", with the synthesis of known radiotracers; 'We envisage this work extending to a wider range of possible fluorodetagging strategies' Gouverneur states. 'The challenge will be to further expand the usefulness of fluorous chemistry in the context of radiochemistry.'

Original publication: Véronique Gouverneur et al., Chem. Commun., 2008.

Royal Society of Chemistry (RSC)

Recommend news PDF version / Print

Share on

Facts, background information, dossiers
  • positron emission t…
  • Fluorination
  • Electrophilic substitution
  • Cross Metathesis
  • AstraZeneca
More about Royal Society of Chemistry
  • News

    Therapeutic screening for Alzheimer’s disease

    Scientists in Canada and the United States have developed a chip sensor for monitoring how drug candidates alter amyloid-β peptide aggregation that they hope could be used to find new treatments for Alzheimer’s disease. Research into Alzheimer’s disease has shown that the self-aggregation o ... more

    Moving the MRI goalposts

    Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly. Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can ov ... more

    High-throughput drug screening in 3D

    Scientists in China have developed a simple microchip that enables quick and inexpensive high-throughput screening of potential drug candidates in 3D cell cultures. Scientists often use cell-based high-throughput screening in the first stage of drug design as a technique to quickly identify ... more

More about University of Oxford
  • News

    OSCAR detects cells in standby mode

    Dormancy is a sleep-like state of cells that protects them from genetic damage and thus prolongs their survival. This state is reversible and characterized by low metabolic activity and division rate. Researchers from the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) and the Un ... more

    Tracking the HI virus

    An international team of researchers led by Dr Cyril Favard and Dr Delphine Muriaux from the Montpellier Infectious Disease Research Institute in collaboration with Prof. Dr Christian Eggeling from the Friedrich Schiller University Jena, the Leibniz Institute of Photonic Technology (Leibniz ... more

    Researchers use AI to establish molecular tumor classification and prognosis in patients with colorectal cancer

    Treating physicians need information about the molecular subtype of the tumor if they are to provide targeted therapy for colorectal carcinoma. A research team from University Hospital Zurich and the University of Oxford have now developed a method to predict the molecular classification of ... more

More about AstraZeneca
  • News

    Thermo Fisher Scientific named a Microsoft Pharmaceutical and Life Sciences Innovation Award winner for Informatics Solutions

    Thermo Fisher Scientific announced that it is the winner of a Microsoft Corporation 2008 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category. The award honors best-in-class companies that have made the most innovative use of Microsoft-based sol ... more

    Out of REACH

    Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ drugs - one of them an anticancer therapy ... more